Central and peripheral dopamine transporter reduction in Parkinson's disease

By Buttarelli Francesca R.   Capriotti Gabriela   Pellicano Clelia   Prosperi Daniela   Circella Annapia   Festa Anna   Giovannelli Morena   Tofani Anna   Pontieri Francesco E.   Scopinaro Francesco  

Neurological Research, Vol. 31, Iss. 7, 2009-09 ,pp. : 687-691

Maney Publishing

Access to resources Recommend Favorite

Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study

By Ceravolo R.   Volterrani D.   Gambaccini G.   Bernardini S.   Rossi C.   Logi C.   Tognoni G.   Manca G.   Mariani G.   Bonuccelli U.   Murri L.  

Journal of Neural Transmission, Vol. 111, Iss. 8, 2004-08 ,pp. : 1065-1073

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson’s disease from essential tremor

By Pellicano C.   Buttarelli F. R.   Circella A.   Tiple D.   Giovannelli M.   Benincasa D.   Colosimo C.   Pontieri F. E.  

Journal of Neural Transmission, Vol. 114, Iss. 7, 2007-07 ,pp. : 935-938

Springer Publishing Company

Access to resources Recommend Favorite

Endogenous dopamine release in Parkinson's disease

By Rinne J.O.  

Lancet Neurology, Vol. 2, Iss. 8, 2003-08 ,pp. : 460-461

Elsevier

Access to resources Recommend Favorite